Microglia As a Pharmacological Target in Infectious and Inflammatory Diseases of the Brain

Overview

Journal J Neuroimmune Pharmacol

Specialties Allergy & Immunology
Neurology
Pharmacology

Date 2007 Nov 28

PMID 18040778

Citations 57

Authors

R Bryan Rock

Phillip K Peterson

Affiliations

Soon will be listed here.

Abstract

Following an eclipse of scientific inquiry regarding the biology of microglia that lasted 50 years, recognition toward the end of the 20th century of their neuropathogenic role in HIV-associated dementia and in neuroinflammatory/neurodegenerative diseases fueled a renaissance of interest in these resident macrophages of the brain parenchyma. Results of a large number of in vitro studies, using isolated microglial cells or glial/neuronal cell cultures, and parallel findings emerging from animal models and clinical studies have demonstrated that activated microglia produce a myriad of inflammatory mediators that both serve important defense functions against invading neurotropic pathogens and have been implicated in brain damage in infectious as well as neuroinflammatory/neurodegenerative diseases, such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. This review provides a brief background regarding the physiological and pathophysiological roles of microglia and highlights current pharmacological approaches that target activated microglia with the goal of ameliorating infectious and neuroinflammatory/neurodegenerative diseases of the brain. Although this aspect of the field of neuroimmunopharmacology is in its infancy, it holds great promise for developing new treatments and prevention of diseases that are, in many cases, epidemic throughout the world.

Citing Articles

Protective role of aconitate decarboxylase 1 in neuroinflammation-induced dysfunctions of the paraventricular thalamus and sleepiness.

Chang J, Li Z, Yuan H, Wang X, Xu J, Yang P Commun Biol. 2024; 7(1):1484.

PMID: 39523388 PMC: 11551151. DOI: 10.1038/s42003-024-07215-0.

Clinical value of macrogenome next-generation sequencing on infections.

Han B, Zhang X, Li X, Chen M, Ma Y, Zhang Y Open Life Sci. 2024; 19(1):20220938.

PMID: 39290502 PMC: 11406221. DOI: 10.1515/biol-2022-0938.

Morphofunctional Features of Microglial Cells during the Administration of Orexin A.

Synchikova A, Korneva E Bull Exp Biol Med. 2023; 174(5):685-688.

PMID: 37043064 DOI: 10.1007/s10517-023-05770-w.

Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer's disease.

McKee C, Hoffos M, Vecchiarelli H, Tremblay M Front Pharmacol. 2023; 14:1125982.

PMID: 36969855 PMC: 10034122. DOI: 10.3389/fphar.2023.1125982.

Baicalin Mitigates the Neuroinflammation through the TLR4/MyD88/NF-B and MAPK Pathways in LPS-Stimulated BV-2 Microglia.

Li B, Wang M, Chen S, Li M, Zeng J, Wu S Biomed Res Int. 2022; 2022:3263446.

PMID: 36408278 PMC: 9668451. DOI: 10.1155/2022/3263446.

References

Blasi E, Barluzzi R, Mazzolla R, Tancini B, Saleppico S, Puliti M . Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J Neuroimmunol. 1995; 58(1):111-6. DOI: 10.1016/0165-5728(95)00016-u. View

Turner M, Cagnin A, Turkheimer F, Miller C, Shaw C, Brooks D . Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004; 15(3):601-9. DOI: 10.1016/j.nbd.2003.12.012. View

Curto M, Reali C, Palmieri G, Scintu F, Schivo M, Sogos V . Inhibition of cytokines expression in human microglia infected by virulent and non-virulent mycobacteria. Neurochem Int. 2003; 44(6):381-92. DOI: 10.1016/j.neuint.2003.08.012. View

Leonard J, DES PREZ R . Tuberculous meningitis. Infect Dis Clin North Am. 1990; 4(4):769-87. View

Lipovsky M, Gekker G, Anderson W, Molitor T, Peterson P, Hoepelman A . Phagocytosis of nonopsonized Cryptococcus neoformans by swine microglia involves CD14 receptors. Clin Immunol Immunopathol. 1997; 84(2):208-11. DOI: 10.1006/clin.1997.4381. View

Lee S, Liu W, Brosnan C, Dickson D . Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab Invest. 1992; 67(4):465-76. View

Si Q, Cosenza M, Kim M, Zhao M, Brownlee M, Goldstein H . A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia. J Neurovirol. 2004; 10(5):284-92. DOI: 10.1080/13550280490499533. View

Chen M, Baidoo K, Verina T, Guilarte T . Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain. 2004; 127(Pt 6):1379-92. DOI: 10.1093/brain/awh161. View

Thomas D, Walker P, Benjamins J, Geddes T, Kuhn D . Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther. 2004; 311(1):1-7. DOI: 10.1124/jpet.104.070961. View

10.

Petersen R, Thomas R, Grundman M, Bennett D, Doody R, Ferris S . Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005; 352(23):2379-88. DOI: 10.1056/NEJMoa050151. View

11.

Fan L, Pang Y, Lin S, Tien L, Ma T, Rhodes P . Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res. 2005; 82(1):71-82. DOI: 10.1002/jnr.20623. View

12.

Rock R, Gekker G, Hu S, Sheng W, Cheeran M, Lokensgard J . Role of microglia in central nervous system infections. Clin Microbiol Rev. 2004; 17(4):942-64, table of contents. PMC: 523558. DOI: 10.1128/CMR.17.4.942-964.2004. View

13.

Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F . Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol. 1999; 25(2):123-33. DOI: 10.1046/j.1365-2990.1999.00167.x. View

14.

Sowa G, Gekker G, Lipovsky M, Hu S, Chao C, Molitor T . Inhibition of swine microglial cell phagocytosis of Cryptococcus neoformans by femtomolar concentrations of morphine. Biochem Pharmacol. 1997; 53(6):823-8. DOI: 10.1016/s0006-2952(97)00006-3. View

15.

Lindberg C, Crisby M, Winblad B, Schultzberg M . Effects of statins on microglia. J Neurosci Res. 2005; 82(1):10-9. DOI: 10.1002/jnr.20615. View

16.

Weydt P, Moller T . Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport. 2005; 16(6):527-31. DOI: 10.1097/00001756-200504250-00001. View

17.

Anthony D, Ferguson B, Matyzak M, Miller K, Esiri M, Perry V . Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol. 1997; 23(5):406-15. View

18.

Cagnin A, Myers R, Gunn R, Lawrence A, Stevens T, Kreutzberg G . In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain. 2001; 124(Pt 10):2014-27. DOI: 10.1093/brain/124.10.2014. View

19.

Lipovsky M, Gekker G, Hu S, Hoepelman A, Peterson P . Morphine enhances complement receptor-mediated phagocytosis of Cryptococcus neoformans by human microglia. Clin Immunol Immunopathol. 1998; 87(2):163-7. DOI: 10.1006/clin.1998.4518. View

20.

Streit W . Microglia as neuroprotective, immunocompetent cells of the CNS. Glia. 2002; 40(2):133-139. DOI: 10.1002/glia.10154. View